Results 251 to 260 of about 501,662 (286)

Radiological, Radiomics, and Metastatic Patterns Associated with Targetable Oncogenic Drivers on CT-Scan of Newly Diagnosed NSCLC Patients: A Comprehensive Radiogenomics Review. [PDF]

Cancers (Basel)
Phan L, Cousin S, Sitruk LA, Masson-Grehaigne C, Lafon M, Kasraoui I, Italiano A, Bonhomme B, Palussière J, Domblides C, Lassau N, Crombé A.   +11 more
europepmc   +1 more source

Study on the diameter design method of vortex settling basin for suspended sediment based on the tangential characteristic Reynolds number. [PDF]

Sci Rep
Wang Y, Li L.
europepmc   +1 more source

The Occurrence of Gene Fusions in Thyroid Lesions and the Relation With Chronic Lymphocytic Thyroiditis. [PDF]

Pathol Int
Jentus MM, van Wezel T, Ruano D, Snel M, Schepers A, Crobach S, Morreau H.   +6 more
europepmc   +1 more source

Rare, Yet Targetable: New Perspectives on Ampullary Carcinomas. [PDF]

Int J Mol Sci
Gutmans J, Friedlaender A, Mechahougui H.   +2 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

RET oncogene

Current Opinion in Genetics & Development, 1996
RET mutations have been identified as the underlying cause of two congenital diseases that predominately affect tissues of neural crest origin: the MEN 2 cancer syndromes and a proportion of cases of dominantly inherited Hirschsprung disease, a disorder of gut development.
Y F, Mak, B A, Ponder
openaire   +2 more sources

RET

2006
The human RET (REarranged during transfection) gene maps on chromosome 10q11.2 and codes for a single pass transmembrane protein.The intracellular portion features a typical tyrosine kinase domain.RET is expressed primarily in peripheral enteric, sympathetic and sensory neurons, and in central motor, dopaminergic and noradrenergic neurons.
VECCHIO, GIANCARLO, FUSCO, ALFREDO, SANTORO, MASSIMO   +2 more
openaire   +3 more sources